Literature DB >> 17684337

Animal models of chronic obstructive pulmonary disease exacerbations.

Gordon J Gaschler1, Carla M T Bauer, Caleb C J Zavitz, Martin R Stämpfli.   

Abstract

Modeling acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in animals has proven challenging due to the clinical and pathological complexity of the underlying disease. This has hindered the progress in understanding the cellular and molecular mechanisms that lie beneath AECOPD. In this chapter, we will address modeling possibilities of AECOPD that may be drawn from the current knowledge of factors that cause exacerbations. Importantly, since it is widely accepted that the most common causes of AECOPD are viral and bacterial infections, animal models of AECOPD should incorporate both the causative agents of exacerbation: viruses and bacteria. However, other factors that are also believed to determine both progression of COPD, as well as the frequency and severity of AECOPD, such as proteolytic enzymes, cigarette smoke or other noxious stimuli must also be considered. Such animal models will provide mechanistic insight into the etiology of AECOPD and will prove invaluable in furthering our understanding of key events in disease pathogenesis.

Entities:  

Mesh:

Year:  2007        PMID: 17684337     DOI: 10.1159/000107059

Source DB:  PubMed          Journal:  Contrib Microbiol        ISSN: 1420-9519


  7 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.

Authors:  Ming Jin; Chang-Jiang Xue; Yu Wang; Fang Dong; Yuan-Yuan Peng; Ya-Dan Zhang; Bao-Xia Zang; Li Tan
Journal:  Chin J Integr Med       Date:  2018-12-27       Impact factor: 1.978

Review 3.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

4.  Exacerbation of cigarette smoke-induced pulmonary inflammation by Staphylococcus aureus enterotoxin B in mice.

Authors:  Wouter Huvenne; Ellen A Lanckacker; Olga Krysko; Ken R Bracke; Tine Demoor; Peter W Hellings; Guy G Brusselle; Guy F Joos; Claus Bachert; Tania Maes
Journal:  Respir Res       Date:  2011-05-27

5.  IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Muriel Pichavant; Riti Sharan; Olivier Le Rouzic; Cécile Olivier; Florence Hennegrave; Gaëlle Rémy; Magdiel Pérez-Cruz; Bachirou Koné; Pierre Gosset; Nicolas Just; Philippe Gosset
Journal:  EBioMedicine       Date:  2015-09-26       Impact factor: 8.143

6.  Integrating murine gene expression studies to understand obstructive lung disease due to chronic inhaled endotoxin.

Authors:  Peggy S Lai; Oliver Hofmann; Rebecca M Baron; Manuela Cernadas; Quanxin Ryan Meng; Herbert S Bresler; David M Brass; Ivana V Yang; David A Schwartz; David C Christiani; Winston Hide
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

7.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.